LUMO - Lumos Pharma Inc Stock Price, Fair Value and News

$4.34

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

LUMO Price Action

LUMO RSI Chart

LUMO Valuation

LUMO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LUMO Fundamentals

LUMO Revenue

LUMO Earnings

LUMO Profitability

LUMO Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.5M	1.5M	2.2M	0
2023	2.1M	2.2M	1.7M	2.1M
2022	553.3K	876.5K	1.2M	1.5M
2021	0	188.7K	209.3K	230.0K
2020	744.0K	552.0K	360.0K	168.0K
2019	9.6M	6.7M	3.8M	936.0K
2018	35.9M	27.7M	22.4M	12.5M
2017	32.8M	41.2M	31.3M	28.7M
2016	35.0M	29.6M	30.7M	35.8M
2015	191.8M	210.9M	230.1M	68.5M
2014	1.1M	1.1M	86.8M	172.6M
2013	1.5M	1.2M	1.1M	1.1M
2012	1.7M	1.8M	1.7M	1.7M
2011	2.0M	2.0M	1.9M	1.9M
2010	0	0	1.5M	2.1M
2009	0	0	0	934.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Lumos Pharma Inc

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

CEO	Mr. Richard J. Hawkins
WEBSITE	https://lumos-pharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	32